|
In Situ CD19.CAR-T Generation Using TRIDENT System for Pediatric B Cell Malignancies |
Baylor College of Medicine |
Cure4Cam Childhood Cancer Foundation, Tap Cancer Out |
|
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine |
Cure4Cam Childhood Cancer Foundation, Tap Cancer Out, Kate's Cause |
|
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida |
Tap Cancer Out, Layla’s Legacy Foundation |
|
Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy |
Research Institute at Nationwide Children's Hospital |
Flashes of Hope, Tap Cancer Out |
|
The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma |
Emory University |
Tap Cancer Out |
|
Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia |
St. Jude Children’s Research Hospital |
Tap Cancer Out |
|
Role of the macro lncRNA KCNQ1OT1 in embryonal rhabdomyosarcoma tumorigenesis |
Duke University |
Tap Cancer Out |
|
Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma |
Ann & Robert H. Lurie Children’s Hospital of Chicago |
Tap Cancer Out |
|
The Impact Of CD56neg NK Cells in the Pathogenesis of Endemic Burkitt Lymphoma |
University of Massachusetts Medical School |
Tap Cancer Out |
|
Modeling H3 G34R and BCOR-Altered Glioma Pathogenesis Using Neural Stem Cells |
The Johns Hopkins University School of Medicine |
Tap Cancer Out |
